Tuesday, October 25, 2011

What Some Wall St. Wags Are Saying. . . On Merck's Q3 2011


Here is one of the Street's prognostications, for Friday morning's coming New Merck earnings call:

. . . .Wall St. Earnings Expectations: The average estimate of analysts is for net income of 91 cents per share, an increase of 7.1% from the company’s actual earnings for the same quarter a year ago. . . . Analysts are projecting profit to increase by 9.1% versus last year to $3.73.

Analysts are projecting a revenuse increase of 4.4% from the year-earlier quarter to $11.61 billion. . . .

Will this be right? Too High? Too low? Do stay tuned, right here. Merck's NYSE-reported common stock price is off 3.7 percent, year to date, just FYI.

3 comments:

Anonymous said...

Don't know if you've been following Cafepharma-but a lot of people are getting axed in NJ.

Condor said...

Yes -- I've seen the threads on CafePharma. . .

I am waiting to get a reliable total -- as to the actual numbers -- then I'll post something. We ought to know that figure by Friday night.

THanks for the tip!

Osborne said...

Quite helpful data, lots of thanks for your article.
youtube to mp3